Page 124

Plenary Biographies Conference Information IOM’s Committee on Prisoners and Research. She currently serves as chair of PRIM&R’s Executive Director Search Committee, and is a member of PRIM&R’s Board of Directors.

Francesca Gould, BA, CCRP, is a regulatory affairs


specialist at Cincinnati Children’s Hospital Medical Center, serving the departments of bone marrow transplantation and immunology. She has over seven years in the field, and has held multiple positions of increasing responsibility. Some of her previous clients include Pfizer, Eli Lilly, Aventis, Wyeth, Novartis, General Electric, Novo Nordisk, Sanofi, Merck, Roche, GlaxoSmithKline, Astra Zeneca, and Amgen. Ms. Gould is the recipient of multiple Pfizer Fish awards, and is a two-time recipient of a Real Leader award (given by her co-workers and managers at INC Research). Ms. Gould holds a bachelor’s degree from Xavier University, where she graduated with honors. She is nearing completion of an MBA from Xavier University and expects, again, to, graduate with honors. Furthermore, she has recently begun studies towards her Master of Science in Health Sciences in clinical research administration at George Washington University. Ms. Gould is an active member of PRIM&R, the Society of Clinical Research Associates, the Association of Clinical Research Professionals, the University of Cincinnati Center for Clinical and Translational Science and Training, and Xavier University’s Women of Excellence. She looks forward to a lifelong career in human subjects protections, and is on a mission to help stop childhood cancer.

Carl Hart, PhD, is an associate professor in the departments of psychology and psychiatry at Columbia University. He is also a research scientist in the Division of Substance Abuse at the New York State Psychiatric Institute. A major focus of Dr. Hart’s research is understanding complex interactions between drugs of abuse and the neurobiology and environmental factors that mediate human behavior and physiology. Dr. Hart is a member of the National Advisory Council on Drug Abuse and sits on the Board of Directors of the College on Problems of Drug Dependence and the Drug Policy Alliance. His new book, High Price: A Neuroscientist’s Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society is a complex story of scientific achievement in the face of overwhelming odds; it also argues that the United States’ drugs policy is misguided and needs to change. Elizabeth Hohmann, MD, is IRB chair and physician director of the Partners HealthCare Human Research Committees covering Massachusetts General Hospital

p rim& r’ s 20 1 3 adv anci ng e th i cal r e s e a rc h c on f e r e n c e

(MGH) and Brigham and Women’s Hospital, two of the major teaching hospitals of Harvard Medical School in Boston, MA. She is an associate professor of medicine in the Infectious Disease Division at MGH, and has research interests in “first in human” translational research and live attenuated bacterial vaccines.

Stephen S. Intille, PhD, SM, BSE, is an associate professor in the College of Computer and Information Science and Bouvé College of Health Sciences at Northeastern University. His research focuses on the development of novel healthcare technologies that incorporate ideas from ubiquitous computing, user-interface design, pattern recognition, behavioral science, and preventive medicine. His areas of special interest include technologies for measuring and motivating health-related behaviors, technologies that support healthy aging and well-being in the home setting, and mobile technologies that permit longitudinal measurement of health behaviors for research, especially the type, duration, intensity, and location of physical activity. Professor Intille received his PhD from the Massachusetts Institute of Technology (MIT) in 1999, working on computational vision at the MIT Media Laboratory, a master’s degree from MIT in 1994, and a BSE degree in computer science and engineering from the University of Pennsylvania in 1992. He has published research on computational stereo depth recovery, real-time and multi-agent tracking, activity recognition, perceptually based interactive environments, and technology for healthcare. In 2012, after 10 years as technology director of the House_n Research Consortium at MIT, he joined Northeastern University to help establish a new transdisciplinary PhD program in personal health informatics. Steven Joffe, MD, MPH, is the Emanuel and Robert

Hart Associate Professor of Medical Ethics and Health Policy at the University of Pennsylvania Perelman School of Medicine. Dr. Joffe attended Harvard College, received his medical degree from University of California, San Francisco (UCSF), and received his Master of Public Health from the University of California, Berkeley. He trained in pediatrics at UCSF and undertook fellowship training in pediatric hematology/ oncology at the Dana-Farber Cancer Institute and Boston Children’s Hospital. His clinical work is in the area of stem cell transplantation in children. His research addresses the many ethical challenges that arise in the conduct of clinical and translational investigation, both in pediatric oncology and other areas of medicine and science. He is the principal investigator (PI) of studies

2013 AER Conference Guide  

Digital version fo the Conference Guide for the 2013 Advancing Ethical Research Conference

2013 AER Conference Guide  

Digital version fo the Conference Guide for the 2013 Advancing Ethical Research Conference